Literature DB >> 15380244

Hitting their targets: an emerging picture of E2F and cell cycle control.

Alexandre Blais1, Brian David Dynlacht.   

Abstract

Understanding the role of transcription factors in governing cell-cycle progression in mammalian cells has been hindered until recently by a relative lack of genetic and genomic approaches. New approaches that harness the power of ChIP and combine this technique with DNA microarrays and bioinformatics have identified direct, physiological targets and have significantly altered our view of the E2F transcription factor that is known to play a role in regulation of cell-cycle progression. Further, the identification of additional E2F family members and factors that function in concert with E2F have considerably expanded our picture of the genetic programs that are governed by this essential regulatory factor.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15380244     DOI: 10.1016/j.gde.2004.07.003

Source DB:  PubMed          Journal:  Curr Opin Genet Dev        ISSN: 0959-437X            Impact factor:   5.578


  65 in total

Review 1.  Opposing roles of E2Fs in cell proliferation and death.

Authors:  Meredith E Crosby; Alexandru Almasan
Journal:  Cancer Biol Ther       Date:  2004-12-21       Impact factor: 4.742

2.  Pocket protein complexes are recruited to distinct targets in quiescent and proliferating cells.

Authors:  Egle Balciunaite; Alexander Spektor; Nathan H Lents; Hugh Cam; Hein Te Riele; Anthony Scime; Michael A Rudnicki; Richard Young; Brian David Dynlacht
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

3.  Comprehensive analysis of transcriptional promoter structure and function in 1% of the human genome.

Authors:  Sara J Cooper; Nathan D Trinklein; Elizabeth D Anton; Loan Nguyen; Richard M Myers
Journal:  Genome Res       Date:  2005-12-12       Impact factor: 9.043

4.  CtIP activates its own and cyclin D1 promoters via the E2F/RB pathway during G1/S progression.

Authors:  Feng Liu; Wen-Hwa Lee
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

5.  Distinct mammalian SWI/SNF chromatin remodeling complexes with opposing roles in cell-cycle control.

Authors:  Norman G Nagl; Xiaomei Wang; Antonia Patsialou; Michael Van Scoy; Elizabeth Moran
Journal:  EMBO J       Date:  2007-01-25       Impact factor: 11.598

6.  Inactivation of the Rb pathway and overexpression of both isoforms of E2F3 are obligate events in bladder tumours with 6p22 amplification.

Authors:  C D Hurst; D C Tomlinson; S V Williams; F M Platt; M A Knowles
Journal:  Oncogene       Date:  2007-11-26       Impact factor: 9.867

7.  Loss of RBF1 changes glutamine catabolism.

Authors:  Brandon N Nicolay; Paulo A Gameiro; Katrin Tschöp; Michael Korenjak; Andreas M Heilmann; John M Asara; Gregory Stephanopoulos; Othon Iliopoulos; Nicholas J Dyson
Journal:  Genes Dev       Date:  2013-01-15       Impact factor: 11.361

Review 8.  Tailoring to RB: tumour suppressor status and therapeutic response.

Authors:  Erik S Knudsen; Karen E Knudsen
Journal:  Nat Rev Cancer       Date:  2008-09       Impact factor: 60.716

9.  A role for mammalian Sin3 in permanent gene silencing.

Authors:  Chris van Oevelen; Jinhua Wang; Patrik Asp; Qin Yan; William G Kaelin; Yuval Kluger; Brian David Dynlacht
Journal:  Mol Cell       Date:  2008-11-07       Impact factor: 17.970

10.  A suppressor screen in chlamydomonas identifies novel components of the retinoblastoma tumor suppressor pathway.

Authors:  Su-Chiung Fang; James G Umen
Journal:  Genetics       Date:  2008-03       Impact factor: 4.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.